• Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

    Not recruiting

    3 1 1 1
    Belgium The Netherlands Spain
  • Study on the Safety and Effects of Plasma Transfusion from Exercise-Trained Donors in Patients with Early Alzheimer’s Disease Using Human Plasma Protein and Saline

    Not recruiting

    2 1 1
    Investigated Diseases:
    Norway
  • Study on How Etrasimod Arginine is Absorbed in Blood and Breast Milk of Healthy Breastfeeding Women with Ulcerative Colitis and Other Inflammatory Disorders

    Not recruiting

    1 1 1
    Investigated Drugs:
    Belgium
  • Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Spain
  • Study on Intradermal COVID-19 mRNA Vaccine (Tozinameran, Famtozinameran) for Elderly Patients Aged 75 and Older

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effects of Camostat Mesilate for Kidney Protection in Patients with Chronic Kidney Disease and Proteinuria

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

    Not recruiting

    3 1 1 1
    Belgium Estonia Finland Germany Italy Poland +1
  • Study on the Effects of Hormonal Contraceptives on the Brain: Comparing Drospirenone and Estetrol with Ethinylestradiol and Levonorgestrel in Women Using Contraception

    Not recruiting

    3 1 1 1
    Sweden
  • Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Belgium Czechia Estonia Finland Germany Greece +3
  • Study on the Effectiveness of the HPV Vaccine in Preventing HPV Infections in Men Who Have Sex with Men Aged 19-26 Using Cervarix

    Not recruiting

    3 1 1 1
    The Netherlands

powered by